Combining brain imaging with dual-task paradigms provides a quantitative, direct metric of cognitive load that is agnostic to the motor task. This work aimed to quantitatively assess cognitive load during activities of daily living-sitting, standing, and walking-using a commercial dry encephalography headset. We recorded participants' brain activity while engaging in a stimulus paradigm that elicited event-related potentials. The stimulus paradigm consisted of an auditory oddball task in which participants had to report the number of oddball tones that were heard during each motor task. We extracted the P3 event-related potential, which is inversely proportional to cognitive load, from EEG signals in each condition. Our main findings showed that P3 was significantly lower during walking compared to sitting (p = .039), suggesting that cognitive load was higher during walking compared to the other activities. There were no significant differences in P3 between sitting and standing. Head motion did not have a significant impact on the measurement of cognitive load. This work validates the use of a commercial dry-EEG headset for measuring cognitive load across different motor tasks. The ability to accurately measure cognitive load in dynamic activities opens new avenues for exploring cognitive-motor interactions in individuals with and without motor impairments. This work highlights the potential of dry EEG for measuring cognitive load in naturalistic settings.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325065 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287885 | PLOS |
Sci Rep
December 2024
Harman International, HarmanX Neurosense, 30001 Cabot Dr, Novi, MI, 48377, USA.
Cognitive load (CL) is one of the leading factors moderating states and performance among drivers. Heavily increased CL may contribute to the development of mental stress. Averaged heart rate (HR) and heart rate variability (HRV) indices are shown to reflect CL levels in different tasks.
View Article and Find Full Text PDFCJC Open
December 2024
University Health Network, Toronto, Ontario, Canada.
Background: Patients with heart failure (HF) can experience a poor quality-of-life (QOL), recurring hospitalizations, and progressive disease symptoms. Patient-reported outcome measures (PROMs) integrate patients' voices into clinical care, by assessing patient symptoms, function, and QOL. In 2022, PROMs were incorporated into the electronic health record system (Epic) at a large academic hospital in Toronto, Ontario, Canada.
View Article and Find Full Text PDFJ Clin Neurosci
December 2024
Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address:
Alzheimer's disease (AD) is the most common cause of dementia, characterized by progressive cognitive and functional decline and is associated with aging. Chronic inflammatory processes are also involved in its the etiology, as the consequence or cause of proteinopathy (amyloid and tau load in the brain). This study aimed to investigate the complete blood count and systemic inflammation indices in 61 individuals with AD, compared to 59 cognitively healthy individuals as controls.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Communication Science and Disorders, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Multi-talker speech intelligibility requires successful separation of the target speech from background speech. Successful speech segregation relies on bottom-up neural coding fidelity of sensory information and top-down effortful listening. Here, we studied the interaction between temporal processing measured using Envelope Following Responses (EFRs) to amplitude modulated tones, and pupil-indexed listening effort, as it related to performance on the Quick Speech-in-Noise (QuickSIN) test in normal-hearing adults.
View Article and Find Full Text PDFBackground: Insomnia is a modifiable risk factor for type 2 diabetes.
Objective: Describe the methodology for the Sleep for Health study, a randomized clinical trial examining the effectiveness of digital cognitive behavioral therapy for insomnia (dCBT-I) in reducing hyperglycemia in 300 people with both insomnia and prediabetes.
Outcomes: Primary outcome is glucose level 2 h after a 75-g glucose load.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!